Di Xiang

819 total citations
27 papers, 559 citations indexed

About

Di Xiang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Di Xiang has authored 27 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Oncology. Recurrent topics in Di Xiang's work include Hematopoietic Stem Cell Transplantation (4 papers), T-cell and Retrovirus Studies (3 papers) and Epigenetics and DNA Methylation (3 papers). Di Xiang is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), T-cell and Retrovirus Studies (3 papers) and Epigenetics and DNA Methylation (3 papers). Di Xiang collaborates with scholars based in China, United States and Hong Kong. Di Xiang's co-authors include Wei Han, Mingyuan Wu, Shunying Zhu, Zhonghui Zhang, Y. Yu, Wen-Shu Wu, Ruiyan Zhang, Jinzhou Zhu, Huili Lu and Yunsheng Yuan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Di Xiang

25 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Di Xiang China	15	284	132	102	101	88	27	559
Yulan Qing United States	11	289 1.0×	276 2.1×	311 3.0×	83 0.8×	111 1.3×	17	698
Paul Bushdid United States	7	320 1.1×	98 0.7×	80 0.8×	150 1.5×	30 0.3×	7	518
Suzanne Nijenhuis Netherlands	6	206 0.7×	123 0.9×	244 2.4×	82 0.8×	60 0.7×	11	756
Maoyun Sun United States	15	373 1.3×	88 0.7×	128 1.3×	73 0.7×	66 0.8×	21	543
Beibei Ni China	15	480 1.7×	133 1.0×	104 1.0×	186 1.8×	26 0.3×	33	740
Andrea S. Rothmeier United States	10	207 0.7×	41 0.3×	124 1.2×	71 0.7×	75 0.9×	12	693
Jin Jiang China	17	403 1.4×	124 0.9×	154 1.5×	222 2.2×	22 0.3×	31	691
Liang Deng China	15	327 1.2×	74 0.6×	62 0.6×	74 0.7×	27 0.3×	42	521

Countries citing papers authored by Di Xiang

Since Specialization

Citations

This map shows the geographic impact of Di Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Xiang more than expected).

Fields of papers citing papers by Di Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Xiang. The network helps show where Di Xiang may publish in the future.

Co-authorship network of co-authors of Di Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Di Xiang. A scholar is included among the top collaborators of Di Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Xiang. Di Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Ensheng, et al.. (2025). Integrative network and computational toxicology reveal the molecular mechanisms in PFOA-induced spermatogenic disorder. Journal of Environmental Management. 386. 125754–125754.

Sheng, Jingyi, Di Xiang, Jiao Yang, et al.. (2018). Epigenetic alterations of a novel antioxidant gene SLC22A3 predispose susceptible individuals to increased risk of esophageal cancer. International Journal of Biological Sciences. 14(12). 1658–1668. 18 indexed citations

Xiang, Di, et al.. (2017). The current status and perspective of metabonomics in breast cancer biomarker research. Scientia Sinica Vitae. 48(1). 15–23. 1 indexed citations

Fu, Li, Zhi Tang, Chi‐Ming Che, et al.. (2016). Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells. Carcinogenesis. 38(1). 94–104. 28 indexed citations

Wu, Mingyuan, Bin Wen, Ningyun Sun, et al.. (2016). Antagonist effect of Interleukin 1 receptor on normal thymopoiesis and thymus toxicity of 5-azacytidine in mouse.. PubMed. 8(2). 1237–45. 3 indexed citations

Zhang, Zhonghui, Di Xiang, Pei Zhu, et al.. (2015). MicroRNA-302/367 Cluster Governs hESC Self-Renewal by Dually Regulating Cell Cycle and Apoptosis Pathways. Stem Cell Reports. 4(4). 645–657. 51 indexed citations

Xiang, Di, Yunsheng Yuan, Li Chen, et al.. (2015). Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes. Biochemical and Biophysical Research Communications. 464(1). 221–228. 16 indexed citations

Zhang, Zhonghui, Di Xiang, & Wenshu Wu. (2014). Sodium Butyrate Facilitates Reprogramming by Derepressing OCT4 Transactivity at the Promoter of Embryonic Stem Cell–Specific miR-302/367 Cluster. Cellular Reprogramming. 16(2). 130–139. 14 indexed citations

Zhang, Zhonghui, et al.. (2013). Dissecting the Roles of miR-302/367 Cluster in Cellular Reprogramming Using TALE-based Repressor and TALEN. Stem Cell Reports. 1(3). 218–225. 44 indexed citations

10.

Shen, Jiaqing, Jing Gao, Jing Zhang, et al.. (2012). Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice. Biomedicine & Pharmacotherapy. 66(2). 83–88. 10 indexed citations

11.

Ren, Tong, Wentao Dong, Yoshinori Takahashi, et al.. (2012). HTLV-2 Tax Immortalizes Human CD4+ Memory T Lymphocytes by Oncogenic Activation and Dysregulation of Autophagy. Journal of Biological Chemistry. 287(41). 34683–34693. 35 indexed citations

12.

Lu, Huili, Shunying Zhu, Di Xiang, et al.. (2012). Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity. Blood. 119(21). 4868–4877. 16 indexed citations

13.

Wu, Zhenqian, Xiaodong Han, Qi Zheng, et al.. (2011). Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model. Biomedicine & Pharmacotherapy. 65(5). 339–344. 21 indexed citations

14.

Zhu, Jinzhou, Jing Zhang, Run Du, et al.. (2011). Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy. 65(7). 481–485. 47 indexed citations

15.

Xiang, Di, Yiping Guo, Jing Zhang, et al.. (2010). Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model. Cancer Chemotherapy and Pharmacology. 67(6). 1445–1453. 20 indexed citations

16.

Wu, Zhenqian, Xiaodong Han, Qi Zheng, et al.. (2010). Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model. Biomedicine & Pharmacotherapy. 64(9). 589–593. 31 indexed citations

17.

Zhu, Jinzhou, Jing Zhang, Di Xiang, et al.. (2010). Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity. European Journal of Pharmacology. 643(2-3). 247–253. 67 indexed citations

18.

Zhao, Mei, Mingyuan Wu, Weiwei Huang, et al.. (2009). Expression, Purification, and Characterization of a Novel Soluble Form of Human Delta-like-1. Applied Biochemistry and Biotechnology. 160(5). 1415–1427. 6 indexed citations

19.

Zhang, Zhonghui, Lijuan Du, Di Xiang, et al.. (2009). Expression and purification of bioactive high-purity human midkine in Escherichia coli. Journal of Zhejiang University SCIENCE B. 10(2). 79–86. 10 indexed citations

20.

Zhang, Jing, Di Xiang, Shunying Zhu, et al.. (2008). Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse. Biomedicine & Pharmacotherapy. 63(7). 501–508. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulan Qing Breakdown of academic impact, for papers by Paul Bushdid Breakdown of academic impact, for papers by Suzanne Nijenhuis Breakdown of academic impact, for papers by Maoyun Sun Breakdown of academic impact, for papers by Beibei Ni Breakdown of academic impact, for papers by Andrea S. Rothmeier Breakdown of academic impact, for papers by Jin Jiang Breakdown of academic impact, for papers by Liang Deng